AI driven growth Splose is actively embedding AI and automation to streamline practice management, signaling a strong opportunity to position advanced automation and AI-enhanced workflows as a key value prop to potential healthcare clients seeking efficiency and scale.

Series A traction Recent $46M Series A funding signals investor confidence and rapid expansion plans, making it an opportune time to engage with Splose about upsell opportunities, enterprise-grade features, and partnerships aligned with growth milestones.

Integrations expansion New integrations with Recoverymetrics and existing tools indicate a strategic emphasis on interoperability; target institutions with multi-system needs and offer complementary integrations to enhance data flow and practice performance.

Market positioning Competitor visibility in psychology and allied health segments suggests Splose targets a broader allied health audience; identify adjacent specialties and tailor messaging around niche compliance, billing automation, and referral management.

Financial health signals Revenue in the mid-range of tens of millions with substantial funding and a growing customer base implies readiness for expanded customer success and premium support packages, as well as scalable implementation services for mid-market practices.